Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01069-4/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_ada25&_hsenc=p2ANqtz-_EG_gJBH57SdJpUcmJTyGAMIIR0DJxJlDSdRNtjMo5ON1Dm4l7xRtUUQq8ywVJfRNRfgW8U4SiR1YyU3gL8KWtAhXxEw&_hsmi=368028124&utm_content=368028124&utm_source=hs_email